These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 834105)

  • 1. 2-Diazomorphine directed antiserum: determination of morphine in brain after naloxone challenge in morphine pellet implanted mice.
    Catlin DH; Schaeffer JC; Liewen MB
    Life Sci; 1977 Jan; 20(1):123-32. PubMed ID: 834105
    [No Abstract]   [Full Text] [Related]  

  • 2. Inability of naloxone to change brain morphine levels in tolerant mice.
    Dum J; Meyer G; Höllt V; Herz A; Catlin DH
    Eur J Pharmacol; 1977 Nov; 46(2):165-70. PubMed ID: 590327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain levels of morphine in mice following removal of a morphine pellet and naloxone challenge: no evidence for displacement.
    Catlin DH; Liewen MB; Schaeffer JC
    Life Sci; 1977 Jan; 20(1):133-9. PubMed ID: 556792
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of immunogenicity of opiates bound to protein at different sites on the molecule: N-carboxy morphine-BSA.
    Herndon BL; Paull K; Baeder H; Ringle DA
    Pharmacol Res Commun; 1976 Jun; 8(3):325-35. PubMed ID: 800261
    [No Abstract]   [Full Text] [Related]  

  • 5. Alterations in the efficacy of naloxone induced by stress, cyclic adenosine monophosphate, and morphine tolerance.
    Harris RA; Loh HH; Way EL
    Eur J Pharmacol; 1976 Sep; 39(1):1-10. PubMed ID: 183962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of etorphine brain concentrations and changes in etorphine-naloxone pA2 values in morphine-pretreated mice.
    Lange DG; Roerig SC; Fujimoto JM; Wang RI
    Biochem Pharmacol; 1981 Jan; 30(2):147-55. PubMed ID: 7236304
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of antimorphine antibodies on an in vitro correlate of antagonist-precipitated opiate abstinence.
    Killian AK; Schuster CR; Wainer BH
    J Pharmacol Exp Ther; 1981 Jun; 217(3):820-7. PubMed ID: 7194910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine dependence and in vivo turnover of acetylcholine in whole mouse brain.
    Cheney DL; Trabucchi M; Hanin I; Costa E
    J Pharmacol Exp Ther; 1975 Nov; 195(2):288-95. PubMed ID: 1237619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action.
    Ngai SH; Berkowitz BA; Yang JC; Hempstead J; Spector S
    Anesthesiology; 1976 May; 44(5):398-401. PubMed ID: 1267205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: The measurement of serum morphine levels by radioimmunoassay following oral administration of diamorphine or morphine.
    Aherne GW; Marks V; Morris BA; Piall EM; Robinson JD; Twycross RG
    Br J Pharmacol; 1975 Jun; 54(2):228P-229P. PubMed ID: 1170912
    [No Abstract]   [Full Text] [Related]  

  • 11. 14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes.
    Bidlack JM; Frey DK; Seyed-Mozaffari A; Archer S
    Biochemistry; 1989 May; 28(10):4333-9. PubMed ID: 2548575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsivity to naloxone during morphine dependence.
    Way EL; Loh HH
    Ann N Y Acad Sci; 1976; 281():252-61. PubMed ID: 14582
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics of mu and delta opioid binding sites in striatal slices of morphine-tolerant and -dependent mice.
    Abdelhamid EE; Takemori AE
    Eur J Pharmacol; 1991 Jun; 198(2-3):157-63. PubMed ID: 1650700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of chronic administration of caffeine on morphine-induced analgesia, tolerance and dependence in mice.
    Ahlijanian MK; Takemori AE
    Eur J Pharmacol; 1986 Jan; 120(1):25-32. PubMed ID: 3005000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reinitiation of sensitivity to naloxone by a single narcotic injection in postaddicted mice.
    Brase DA; Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 May; 197(2):317-25. PubMed ID: 944771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereospecific and nonstereospecific effects of (+)- and (-)-morphine: evidence for a new class of receptors?
    Jacquet YF; Klee WA; Rice KC; Iijima I; Minamikawa J
    Science; 1977 Nov; 198(4319):842-5. PubMed ID: 199942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of (+)- and (-)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice.
    Eriksen GS; Andersen JM; Boix F; Bergh MS; Vindenes V; Rice KC; Huestis MA; Mørland J
    J Pharmacol Exp Ther; 2016 Aug; 358(2):209-15. PubMed ID: 27278234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of morphine and naloxone on intestinal transit in mice.
    Wong CL; Roberts MB; Wai MK
    Eur J Pharmacol; 1980 Jun; 64(4):289-95. PubMed ID: 7190096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine release and displacement by naloxone in vivo in morphine naive and withdrawn rats.
    Dwoskin LP; Sprague GL; Takemori AE; Sparber SB
    Life Sci; 1980 Feb; 26(5):377-85. PubMed ID: 7189229
    [No Abstract]   [Full Text] [Related]  

  • 20. Alterations in the antagonism by naloxone of morphine-induced respiratory depression and analgesia after morphine pretreatment.
    McGilliard KL; Takemori AE
    J Pharmacol Exp Ther; 1978 Dec; 207(3):884-91. PubMed ID: 731438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.